Leslie Bucheit

8PUBLICATIONS
66CO-AUTHORS
Disease surveillanceMolecular targetsPredictive and prognostic markersCancer geneticsCounselling, wellbeing and community services
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 03, 2026
Longitudinal, Retrospective Use of a Circulating Tumor DNA Methylation Signature Successfully Captures Small Cell Evolution in a Patient With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer.

Tejas Patil, Amy Guimarães-Young, Jill Tsai

|Feb 26, 2026
Characterizing Longitudinal Molecular Changes in ctDNA in Patients with Metastatic Castration-Resistant Prostate Cancer.

Chinmay T Jani, Eli Tran, Nicole Zhang

|Dec 02, 2024
Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers.

Reagan M Barnett, Albert Jang, Sree Lanka

|Jun 12, 2024
Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study.

Susanna Slater, Annette Bryant, Maria Aresu

|Sep 28, 2023
Pan-Cancer Prevalence of Microsatellite Instability-High (MSI-H) Identified by Circulating Tumor DNA and Associated Real-World Clinical Outcomes.

Pashtoon Murtaza Kasi, Leslie A Bucheit, Jiemin Liao

|May 04, 2023
Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis.

Lorenzo Gerratana, Andrew A Davis, Marko Velimirovic

Pageof 2

Frequent Collaborators

2 joint publications

Pedro Barata

1 joint publications

Chloe Barnett

1 joint publications

Pashtoon Murtaza Kasi

1 joint publications

Jiemin Liao